The Exchange has sought clarification from Natco Pharma Ltd with respect to the disclosure dated December 5, 2014 submitted by Natco Pharma Ltd which inter-alia states "Allotment of Equity Shares on Preferential Basis other than Cash" <BR> <BR>Natco Pharma Ltd was requested to submit its clarification to the Exchange with respect to the following in terms of Clause 36 of the Listing Agreement. <BR><BR>i. Issue period;<BR>ii. Names of the investors and of these, which are promoters or promoter group entities,<BR>iii. Post allotment of securities:- outcome of the subscription, issue price / allotted price (in case of convertibles), number of investors<BR> <BR>Natco Pharma Ltd response is enclosed. Also Company has referred to the AGM notice submitted along with the Annual Report 2014.
|